US2006052033A1PendingUtilityA1
Medicated breast pad
Assignee: FIRST YEARS INC A MASSACHUSETTPriority: Mar 25, 2003Filed: Oct 31, 2005Published: Mar 9, 2006
Est. expiryMar 25, 2023(expired)· nominal 20-yr term from priority
A61F 2013/15016A61F 13/8405A61F 13/141
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A breast pad has a wax-like medicament, such as lanolin, disposed on an exposed surface of an inner surface of the pad in only a limited region, leaving other regions of the inner surface has a permeable region free of the medicament.
Claims
exact text as granted — not AI-modified1 . A breast pad comprising:
a core containing absorbent material; and a liquid impermeable cover disposed on an outer side of the core; wherein an inner surface of the core contains a wax-like medicament in a limited region thereof, such that the inner surface allows for absorption into the breast pad through a remaining medicament-free region of the inner surface of the core.
2 . The breast pad of claim 1 comprising between about 0.03 and 0.15 grams of medicament.
3 . (canceled)
4 . The breast pad of claim 1 wherein the medicament-free region comprises between about 30 and 50 percent of a total exposed surface area of the inner surface.
5 . (canceled)
6 . The breast pad of claim 1 wherein at least about 50 percent of a total exposed surface area of the inner surface is medicament-free.
7 . The breast pad of claim 1 wherein the limited region of medicament includes a central portion of the breast pad.
8 . The breast pad of claim 7 wherein the medicament is distributed uniformly within the central portion.
9 . The breast pad of claim 8 wherein the central portion is surrounded by the medicament-free region.
10 . The breast pad of claim 9 wherein the medicament-free region has a width of at least about 15 millimeters.
11 . The breast pad of claim 7 wherein the central portion includes both medicament and medicament-free areas.
12 . The breast pad of claim 1 wherein the medicament is in the form of a coating on the inner surface.
13 . The breast pad of claim 1 wherein the medicament is in the form of a dispersion on the inner surface.
14 - 17 . (canceled)
18 . The breast pad of claim 1 wherein the medicament comprises lanolin.
19 . A breast pad comprising:
an inner surface for contacting a mammary gland; wherein the inner surface has a first region with a wax-like medicament and a second region that is free of wax-like medicaments; and wherein the second region is permeable to fluids and permits absorption of mammary into the breast pad.
20 . The breast pad of claim 19 comprising between about 0.03 and 0.15 grams of medicament.
21 . (canceled)
22 . The breast pad of claim 19 wherein the region that is free of wax-like medicaments comprises between about 30 and 50 percent of a total exposed surface area of the inner surface.
23 . (canceled)
24 . The breast pad of claim 19 wherein at least about 50 percent of a total exposed surface area of the inner surface is the region that is free of wax-like medicaments.
25 . The breast pad of claim 19 wherein the medicament is in the form of a coating on the inner surface.
26 . The breast pad of claim 19 wherein the medicament is in the form of a dispersion on the inner surface.
27 - 29 . (canceled)
30 . The breast pad of claim 19 wherein the medicament comprises lanolin.
31 . A method of absorbing mammary fluids while soothing skin, the method comprising
providing a breast pad having an inner surface with a first region containing a wax-like medicament, and a second region that is free of wax-like medicaments and is permeable to permit absorption of mammary fluid into the pad; and placing the breast pad on a human mammary gland, with the first region contacting at least a portion of an areola of the mammary gland and the permeable second region contacting the mammary gland for absorption of fluids.
32 . The method of claim 31 wherein the first region of the inner surface comprises between about 0.03 and 0.15 grams of medicament.
33 . The method of claim 31 wherein the first region of the inner surface is fluid impermeable.
34 . The method of claim 31 wherein the medicament comprises lanolin.Join the waitlist — get patent alerts
Track US2006052033A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.